Position in NRIX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$3,674,249
-$31,898,623 QoQ
Shares Held
151,453
-93.4% QoQ
Ownership
0.146%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 210 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. NRIX ranks #75 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in NRIX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,674,249 | 151,453 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $35,572,872 | 2,295,024 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $47,174,444 | 2,486,792 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $13,295,057 | 1,438,859 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,201,520 | 368,878 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $4,516,157 | 380,148 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $10,007,751 | 531,197 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $19,204,704 | 854,682 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $21,879,982 | 1,048,394 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $22,040,709 | 1,499,368 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $5,203,395 | 504,205 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $154,016 | 19,595 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $157,382 | 15,754 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $252,306 | 28,413 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $216,811 | 19,746 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $253,251 | 19,436 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $265,601 | 20,963 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $251,506 | 17,952 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $578,131 | 19,970 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $578,017 | 19,293 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $527,283 | 19,875 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $489,511 | 15,745 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $428,623 | 13,036 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $207,050 | 5,931 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||